27389 Rapid and sustained improvement in itch in children aged 6–11 years with severe atopic dermatitis (AD) treated with dupilumab: Analysis from the LIBERTY AD PEDS phase 3 trial

Journal article

Amy S Paller, Elaine C Siegfried, Gil Yosipovitch, Jonathan I Silverberg, Jashin J Wu, Zhen Chen, Randy Prescilla, Ana B Rossi and Dimittri Delevry

Journal of the American Academy of Dermatology, Vol.85(3), pp.AB140-AB140

2021-09

Metrics

6 Record Views

Title: 27389 Rapid and sustained improvement in itch in children aged 6–11 years with severe atopic dermatitis (AD) treated with dupilumab: Analysis from the LIBERTY AD PEDS phase 3 trial
Creators: Amy S Paller - Northwestern University Feinberg School of Medicine, Chicago, IL
Elaine C Siegfried - Saint Louis University and Cardinal Glennon Children’s Hospital, St. Louis, MO
Gil Yosipovitch - University of Miami
Jonathan I Silverberg - George Washington University
Jashin J Wu - Dermatology Research and Education Foundation
Zhen Chen - Regeneron
Randy Prescilla - Sanofi Genzyme, Cambridge, MA
Ana B Rossi - Sanofi Genzyme, Cambridge, MA
Dimittri Delevry - Regeneron
Publication Details: Journal of the American Academy of Dermatology, Vol.85(3), pp.AB140-AB140
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Dermatology & Cutaneous Surgery
Language: English
Resource Type: Journal article
Record Identifier: 991031714068302976